Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004219 |
---|---|
Receipt number | R000005070 |
Scientific Title | Phase II trial of FOLFIRI plus Bevacizumab in second-line therapy after progression on bevacizumab with oxaliplatine-based chemotherapy in patients with metastatic colorectal cancer whose KRAS status are investigated. |
Date of disclosure of the study information | 2010/09/16 |
Last modified on | 2012/03/15 19:58:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/15 21:51:35 | ||
2 | Update | 2012/03/15 19:58:11 | Recruitment status Date trial data considered complete |